Abiopharma

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001317 Size: 30 KB

Director BARABE TIMOTHY C 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000032

English Emily 🟢 acquired 95.0K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000031

Director Thompson Craig B. 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000001

Director Singer Michael 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000030

Director SPRINGER TIMOTHY A 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000029

Director Kalayoglu Murat 🟢 acquired 10.4K shares (1 derivative) of Cartesian Therapeutics, Inc. (RNAC) at $6.76 Transaction Date: Jan 02, 2026 | Filing ID: 000028

Urist Marshall 🔴 sold 20.0K shares of Royalty Pharma plc (RPRX) at $38.48 Transaction Date: Jan 02, 2026 | Filing ID: 000002

MOORHEAD DANIEL J 🟢 acquired 70.0K shares (1 derivative) of Beyond Air, Inc. (XAIR) at $0.79 Transaction Date: Jan 05, 2026 | Filing ID: 000609

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001314 Size: 30 KB

UTHR: Notification

UTHR: Notification

New Form DEF 14A - ADIAL PHARMACEUTICALS, INC. Filed: 2026-01-06 AccNo: 0001213900-26-001792 Size: 647 KB

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001310 Size: 30 KB

Director SING GEORGE L 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002